Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model Meeting Abstract
| Authors: | Alvim, R.; Nogueira, L.; Georgala, P. M.; Somma, A.; Nagar, K.; Thomas, J.; Ledbai, S.; Hudges, C.; Scherz, A. J.; Zanganeh, S. M.; Kim, K.; Coleman, J. |
| Abstract Title: | Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368306162 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e17004 |
| Notes: | Meeting Abstract: e17004 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
